Open the mobile version, with barcode scanning
Class I Terminated

Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801, NDC 59746-122…

Why: Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride

Company
Jubilant Cadista Pharmaceuticals, Inc.
Salisbury, MD, United States
Reported
Apr 6, 2022
Recall started
Mar 8, 2022
Ended
Nov 15, 2022
Where sold
Product was distributed in Arkansas, Florida, North Carolina, South Carolina and Ohio.
Amount
12,174 bottles
Full product description
Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801, NDC 59746-122-06
Lots / codes affected
Lot # 22P0036, Exp 12/2024

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.